Vanguard Group
MNPR icon

Vanguard Group’s Monopar Therapeutics MNPR Stock Holding History

Vanguard Group’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$19.2M Buy
293,816
+85,598
+41% +$6.99M ﹤0.01% 2633
2025
Q3 		$17M Buy
208,218
+121,729
+141% +$5.44M ﹤0.01% 2706
2025
Q2 		$3.09M Buy
86,489
+31,255
+57% +$1.14M ﹤0.01% 3379
2025
Q1 		$2.01M Sell
55,234
-1,275
-2% -$45.9K ﹤0.01% 3489
2024
Q4 		$1.24M Buy
+56,509
New +$948K ﹤0.01% 3696
2024
Q3 		– Sell
-9,033
Closed -$33K – 4365
2024
Q2 		$33K Hold
9,033
– – ﹤0.01% 4322
2024
Q1 		$30.8K Hold
9,033
– – ﹤0.01% 4359
2023
Q4 		$15.4K Sell
9,033
-8,486
-48% -$17.2K ﹤0.01% 4462
2023
Q3 		$54.3K Sell
17,519
-2,316
-12% -$8.09K ﹤0.01% 4404
2023
Q2 		$84.8K Sell
19,835
-160
-0.8% -$818 ﹤0.01% 4405
2023
Q1 		$139K Hold
19,995
– – ﹤0.01% 4370
2022
Q4 		$237K Buy
19,995
+19
+0.1% +$232 ﹤0.01% 4277
2022
Q3 		$152K Hold
19,976
– – ﹤0.01% 4455
2022
Q2 		$230K Hold
19,976
– – ﹤0.01% 4455
2022
Q1 		$255K Hold
19,976
– – ﹤0.01% 4502
2021
Q4 		$321K Hold
19,976
– – ﹤0.01% 4498
2021
Q3 		$487K Buy
19,976
+484
+2% +$12.5K ﹤0.01% 4379
2021
Q2 		$574K Buy
19,492
+10,478
+116% +$300K ﹤0.01% 4248
2021
Q1 		$279K Buy
+9,014
New +$329K ﹤0.01% 4220

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group's MNPR Position: Q4 2025 in Review

Vanguard Group increased its Monopar Therapeutics (MNPR) stake by 41% in Q4 2025, buying an estimated $6.99M and bringing the position to 293,816 shares worth $19.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Vanguard Group first reported a position in MNPR in Q1 2021 and has held it in 19 quarters since. 74 funds tracked by Wall St. Rank hold MNPR as of Q4 2025.

  • Vanguard Group held 293,816 shares of Monopar Therapeutics worth $19.2M as of Q4 2025.
  • Vanguard Group bought 85,598 Monopar Therapeutics shares in Q4 2025, an estimated $6.99M.
  • Monopar Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2633 holding.
  • Vanguard Group first reported a position in Monopar Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • 74 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.